Factors Associated With Regorafenib Adherence With Metastatic Colorectal Cancer

INTRODUCTION: Regorafenib is an oral multikinase inhibitor for the treatment of metastatic colorectal cancer (mCRC). The clinical factors that may affect adherence to regorafenib remain unclear. The aim of this study was to evaluate adherence to regorafenib with mCRC and to identify factors that mig...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Patient Prefer Adherence
Main Authors: Kawakami, Kazuyoshi, Wakatsuki, Takeru, Soejima, Azusa, Kobayashi, Kazuo, Yokokawa, Takashi, Aoyama, Takeshi, Suzuki, Kenichi, Suenaga, Mitsukuni, Yamaguchi, Kensei, Inoue, Ayaka, Machida, Yoshiaki, Hama, Toshihiro
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6800560/
https://ncbi.nlm.nih.gov/pubmed/31686792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S217835
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados